Carbamazepine Tablet, Extended Release
Product Images NDC 51672-4125

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 51672-4125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical structure of carbamazepine, showing the fused aromatic rings and the amide functional group attached to the central ring system.*

FDA Label Image

Principal Display Panel (100 mg Chewable Tablet Bottle Label)

Label for Carbamazepine 100 mg chewable tablets, showing it is a prescription drug by Sun Pharmaceutical Industries, Inc. The label indicates storage instructions, pharmacist dispensing notes, and manufacturer details by Taro Pharmaceutical Industries Ltd. The package contains 500 tablets. Dosage and handling directions are also visible.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Label for Carbamazepine Tablets USP 200 mg, chewable tablets with quantity of 1000 tablets. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label includes storage instructions and a note to dispense accompanying medication guide to patients. Marked Rx only.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 100 mg, a prescription oral tablet product by Sun Pharmaceutical Industries, Inc. The label includes dosing instructions, storage conditions (20° to 25°C), and manufacturer information including Taro Pharmaceutical Industries Ltd. The package contains 100 tablets and emphasizes the tablets must be swallowed whole and dispensed in a tight container.*

FDA Label Image

Principal Display Panel (200 mg Extended-Release Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 200 mg shows a package containing 100 tablets. The label includes dosing instructions, storage conditions, and manufacturer details of Taro Pharmaceutical Industries Ltd. It is marked Rx only and advises dispensing a medication guide with each prescription.*

FDA Label Image

Principal Display Panel (400 mg Extended-Release Tablet Bottle Label)

Label for Carbamazepine Extended-Release Tablets USP 400 mg in tablet form. The label indicates 100 tablets per container, with the dosage form as extended-release tablets. It includes storage instructions and manufacturer information for Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. The label features the NDC 51672-4125-1 and states Rx only.*

FDA Label Image

Principal Display Panel (100 mg/5 mL Bottle Label)

Label for Carbamazepine Oral Suspension USP, 100 mg/5 mL, liquid medication in a 450 mL container. The label emphasizes shaking well before use and includes dosing and storage instructions. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.